v3.25.2
Composition of Certain Consolidated Financial Statement Line Items - Accrued expenses and other current liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Composition of Certain Consolidated Financial Statement Line Items    
Accrued compensation $ 5,589 $ 7,290
Accrued research and development expenses 9,679 5,460
Accrued clinical expenses 8,000 7,025
Accrued professional services 2,884 2,918
Accrued other liabilities 1,227 3,606
Total accrued expenses and other current liabilities $ 27,379 $ 26,299